Tilray Brands, Inc. (TLRY) Consolidates its Global Medical Offering into Tilray Medical

Tilray Brands Consolidates its Global Medical Offering into Tilray Medical, a Comprehensive…

The post Tilray Brands, Inc. (TLRY) Consolidates its Global Medical Offering into Tilray Medical appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Best US Marijuana Stocks To Watch Before Federal Cannabis Reform
NCIA Board of Directors Selects 2022 Officers
by Aaron Smith, NCIA’s CEO and Co-founder On Monday, February 7, NCIA’s Board of Directors conducted its first meeting of the year and gladly welcomed Michael Cooper of Madison Jay Solutions and Peoples’ Ecosystem CEO Christine De La Rosa as newly-seated members of the leadership team. A longtime member... Read more
InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue – 3 Times YoY and 24% QoQ Growth Estimated revenue reaches over CAD$31 million (a record NIS 77 million) Anticipates continued increases in adjusted operating profit and EBITDA Revenue growth expected to continue throughout 2022 TORONTO and HERZLIYA, Israel, Feb. 08,... Read more
FARMACEUTICALRX Closes $34.0 Million In Debt Financing From Chicago Atlantic to Expand its Medical Marijuana Operations in Ohio CHICAGO and PITTSBURGH, Feb. 08, 2022 (GLOBE NEWSWIRE) — FARMACEUTICALRX, one of the largest producers of premium organic medical marijuana products in the US market, (“FARMACEUTICALRX” or the “Company”), today announced that... Read more
Red White & Bloom Closes Acquisition of PharmaCo with 21 Cannabis Licenses State transfers 21 medical and adult-use cannabis licenses to RWB Michigan, LLC. Acquisition includes: Eight fully operating dispensaries (five dually licensed); Two operational indoor cultivation facilities totaling over 30,000 sq. ft.; One municipally licensed 10-acre outdoor cultivation... Read more
Exclusive Interview with Glass House Brands Co-Founder, Chairman and CEO Kyle Kazan Glass House Brands (NEO: GLAS.A.U) (OTCQX: GLASF) is pursuing the ambitious goal of rolling out the largest cultivation footprint in cannabis. The California-centric company may be a single-state operator, but it has an enterprise value of more... Read more
What We Learned from the New York City Cannabis Conversation

What did we learn from last week’s Office of Cannabis Management’s (OCM) New York City Cannabis Conversation? A few things. But first, a refresher: earlier this year the OCM and the Cannabis Control Board rolled out a series of virtual community engagement meetings. The Cannabis Conversations are intended to allow: “New Yorkers [to] hear directly

The post What We Learned from the New York City Cannabis Conversation appeared first on Harris Bricken.

Read more
The NFL and Medical Marijuana

It’s Super Bowl week! Over the years, we’ve written occasionally about marijuana issues and the National Football League. See here, here, and here, for example. As more states legalize marijuana, its prevalence in NFL cities is only increasing. This year, the Super Bowl will be in my backyard in Los Angeles (GO RAMS!), and I have

The post The NFL and Medical Marijuana appeared first on Harris Bricken.

Read more
Clearmind Medicine Secures CAD$1.6 Million in Private Placement
Ryan Allway February 8th, 2022 Psychedelics, Top News Clearmind and Medigus, the investor, intend to form a joint venture in the field of food industry, based on Clearmind’s unique psychedelics IP TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTCMKTS: CMNDF) (“Clearmind” or the “Company“), a... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )